[Hepatogenous (secondary) aldosteronism (author's transl)].
D000450:Aldosterone / Q000378:metabolism; D000804:Angiotensin II / Q000502:physiology; D002908:Chronic Disease; D004932:Esophageal and Gastric Varices / Q000150:complications; D006505:Hepatitis / Q000150:complications; D006506:Hepatitis A / Q000150:complications; D006801:Humans; D006929:Hyperaldosteronism / Q000188:drug therapy / Q000209:etiology*; D008107:Liver Diseases / Q000150:complications* / Q000378:metabolism; D008111:Liver Function Tests; D011167:Portacaval Shunt, Surgical / Q000009:adverse effects; D012083:Renin / Q000502:physiology; D013148:Spironolactone / Q000627:therapeutic use; D014867:Water; D014882:Water-Electrolyte Balance
D014867:Water; D000804:Angiotensin II; D013148:Spironolactone; D000450:Aldosterone; D012083:Renin
Hepatogener (sekundärer) aldosteronismus.